Press release
Ischemic Stroke Therapeutics- Pipeline Analysis 2018 | Lumosa Therapeutics Co., Ltd., International Stem Cell Corporation, NoNO Inc
Download the sample report @ https://www.pharmaproff.com/request-sample/1103
According to the American Stroke Association, strokes are the second leading cause of death in the world. Several risk factors associated with the ischemic stroke are high blood pressure, diabetes, atrial fibrillation, high cholesterol level, obesity, inactivity, unhealthy diet, smoking, and aging.
Get the detailed analysis @ https://www.pharmaproff.com/report/ischemic-stroke-therapeutics-pipeline-analysis
Lumosa Therapeutics Co. Ltd. is in the process of developing LT – 3001 as a small molecule with thrombolytic and anti-oxidative functions for the treatment of acute ischemic stroke. Some of the other companies having pipeline drugs for ischemic stroke includes International Stem Cell Corporation, and NoNO Inc.
Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1103
• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.
About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.
Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ischemic Stroke Therapeutics- Pipeline Analysis 2018 | Lumosa Therapeutics Co., Ltd., International Stem Cell Corporation, NoNO Inc here
News-ID: 1754098 • Views: …
More Releases for Lumosa
Acute Ischemic Stroke Market Set to Grow Substantially Through 2034, DelveInsigh …
The Key Acute Ischemic Stroke Companies in the market include - Acticor Biotech, Athersys/Healios K.K., Bristol-Myers Squibb, Lumosa Therapeutics, Abbvie, and others.
The Acute Ischemic Stroke market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acute Ischemic Stroke pipeline products will significantly revolutionize the Acute Ischemic Stroke market dynamics.
DelveInsight's "Acute Ischemic Stroke Market Insights, Epidemiology, and Market Forecast-2034 report…
Acute Ischemic Stroke Market Predicted to See Upsurge Through 2034, Highlights D …
The Key Acute Ischemic Stroke Companies in the market include - Acticor Biotech, Athersys/Healios K.K., Bristol-Myers Squibb, Lumosa Therapeutics, Abbvie, and others.
The Acute Ischemic Stroke market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acute Ischemic Stroke pipeline products will significantly revolutionize the Acute Ischemic Stroke market dynamics.
DelveInsight's "Acute Ischemic Stroke Market Insights, Epidemiology, and Market Forecast-2034 report…
Acute Ischemic Stroke Market Growth to Accelerate in Forecast Period (2024-2034) …
The Acute Ischemic Stroke market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acute Ischemic Stroke pipeline products will significantly revolutionize the Acute Ischemic Stroke market dynamics.
DelveInsight's "Acute Ischemic Stroke Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Acute Ischemic Stroke, historical and forecasted epidemiology as well as the Acute Ischemic…
Acute Ischemic Stroke Market to Show Remarkable Growth Trends from 2023 to 2032, …
The Acute Ischemic Stroke market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acute Ischemic Stroke pipeline products will significantly revolutionize the Acute Ischemic Stroke market dynamics.
DelveInsight's "Acute Ischemic Stroke Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Acute Ischemic Stroke, historical and forecasted epidemiology as well as the Acute Ischemic…
Ischemic Stroke Market to Register Incremental Growth During the Forecast Period …
The Ischemic Stroke market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Ischemic Stroke pipeline products will significantly revolutionize the Ischemic Stroke market dynamics.
DelveInsight's "Ischemic Stroke Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Ischemic Stroke, historical and forecasted epidemiology as well as the Ischemic Stroke market trends in the United…
Ischemic Stroke Market to Register Incremental Growth During the Forecast Period …
The Ischemic Stroke market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Ischemic Stroke pipeline products will significantly revolutionize the Ischemic Stroke market dynamics.
DelveInsight's "Ischemic Stroke Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Ischemic Stroke, historical and forecasted epidemiology as well as the Ischemic Stroke market trends in the United States, EU5…
